288 related articles for article (PubMed ID: 33500102)
1. Metabolic syndrome, high-sensitivity C-reactive protein levels and the risk of new-onset atrial fibrillation: Results from the Kailuan Study.
Wang Z; Wang B; Li X; Zhang S; Wu S; Xia Y
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):102-109. PubMed ID: 33500102
[TBL] [Abstract][Full Text] [Related]
2. Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study.
Song M; Liu T; Liu H; Zhang Q; Zhang Q; Wang Y; Ma X; Cao L; Shi H
BMC Cancer; 2022 Aug; 22(1):853. PubMed ID: 35927639
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and atrial fibrillation: Insights from epidemiological and Mendelian randomization studies.
Li X; Peng S; Wu X; Guan B; Tse G; Chen S; Zhou G; Wei Y; Gong C; Lu X; Xu J; Wu S; Liu S
Nutr Metab Cardiovasc Dis; 2022 Jun; 32(6):1519-1527. PubMed ID: 35428542
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: the Tromsø study.
Nyrnes A; Njølstad I; Mathiesen EB; Wilsgaard T; Hansen JB; Skjelbakken T; Jørgensen L; Løchen ML
Gend Med; 2012 Dec; 9(6):536-547.e2. PubMed ID: 23046763
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
[TBL] [Abstract][Full Text] [Related]
6. The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion.
Celebi OO; Celebi S; Canbay A; Ergun G; Aydogdu S; Diker E
Cardiology; 2011; 118(3):168-74. PubMed ID: 21654170
[TBL] [Abstract][Full Text] [Related]
7. High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study).
Dawood FZ; Judd S; Howard VJ; Limdi NA; Meschia JF; Cushman M; Howard G; Herrington DM; Soliman EZ
Am J Cardiol; 2016 Dec; 118(12):1826-1830. PubMed ID: 27712649
[TBL] [Abstract][Full Text] [Related]
8. Lipid profile and incidence of atrial fibrillation: A prospective cohort study in China.
Li X; Gao L; Wang Z; Guan B; Guan X; Wang B; Han X; Xiao X; Waleed KB; Chandran C; Wu S; Xia Y
Clin Cardiol; 2018 Mar; 41(3):314-320. PubMed ID: 29575115
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion.
Watanabe E; Arakawa T; Uchiyama T; Kodama I; Hishida H
Int J Cardiol; 2006 Apr; 108(3):346-53. PubMed ID: 15964643
[TBL] [Abstract][Full Text] [Related]
10. Serum High-Sensitivity C-Reactive Protein Levels and the Risk of Atrial Fibrillation in Japanese Population: the Circulatory Risk in Communities Study.
Tanaka M; Imano H; Kubota Y; Yamagishi K; Umesawa M; Muraki I; Cui R; Hayama-Terada M; Shimizu Y; Okada T; Ohira T; Sankai T; Tanigawa T; Sato S; Kitamura A; Kiyama M; Iso H;
J Atheroscler Thromb; 2021 Feb; 28(2):194-202. PubMed ID: 32522907
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study.
Chang SN; Lai LP; Chiang FT; Lin JL; Hwang JJ; Tsai CT
J Thromb Haemost; 2017 Aug; 15(8):1541-1546. PubMed ID: 28498565
[TBL] [Abstract][Full Text] [Related]
12. Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease.
Nortamo S; Ukkola O; Lepojärvi S; Kenttä T; Kiviniemi A; Junttila J; Huikuri H; Perkiömäki J
Int J Cardiol; 2017 Dec; 248():173-178. PubMed ID: 28942872
[TBL] [Abstract][Full Text] [Related]
13. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis.
Selcuk MT; Selcuk H; Maden O; Temizhan A; Aksu T; Dogan M; Sasmaz A
J Heart Valve Dis; 2007 Sep; 16(5):468-74. PubMed ID: 17944117
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation.
Lin YJ; Tsao HM; Chang SL; Lo LW; Tuan TC; Hu YF; Udyavar AR; Tsai WC; Chang CJ; Tai CT; Lee PC; Suenari K; Huang SY; Nguyen HT; Chen SA
Am J Cardiol; 2010 Feb; 105(4):495-501. PubMed ID: 20152244
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein and atrial fibrillation in idiopathic dilated cardiomyopathy.
Dai S; Zhang S; Guo Yh; Chu J; Hua W; Wang Fz
Clin Cardiol; 2009 Sep; 32(9):E45-50. PubMed ID: 19645035
[TBL] [Abstract][Full Text] [Related]
16. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease.
Wang A; Liu J; Li C; Gao J; Li X; Chen S; Wu S; Ding H; Fan H; Hou S
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066453
[TBL] [Abstract][Full Text] [Related]
17. Single and persistent elevation of C-reactive protein levels and the risk of atrial fibrillation in a general population: The Ansan-Ansung Cohort of the Korean Genome and Epidemiology Study.
Lee Y; Park HC; Shin JH; Lim YH; Shin J; Park JK
Int J Cardiol; 2019 Feb; 277():240-246. PubMed ID: 30409736
[TBL] [Abstract][Full Text] [Related]
18. High sensitive C-reactive protein and interleukin 6 in atrial fibrillation with rheumatic mitral stenosis from Indian cohort.
Sharma G; Shetkar S; Bhasin A; Ramakrishnan L; Juneja R; Naik N; Roy A; Ramakrishnan S; Bhargava B; Bahl VK
Indian Heart J; 2017; 69(4):505-511. PubMed ID: 28822519
[TBL] [Abstract][Full Text] [Related]
19. NT-proBNP is a powerful predictor for incident atrial fibrillation - Validation of a multimarker approach.
Svennberg E; Lindahl B; Berglund L; Eggers KM; Venge P; Zethelius B; Rosenqvist M; Lind L; Hijazi Z
Int J Cardiol; 2016 Nov; 223():74-81. PubMed ID: 27541645
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial Fibrillation.
Benz AP; Aeschbacher S; Krisai P; Moschovitis G; Blum S; Meyre P; Blum MR; Rodondi N; Di Valentino M; Kobza R; De Perna ML; Bonati LH; Beer JH; Kühne M; Osswald S; Conen D;
J Am Heart Assoc; 2021 Apr; 10(8):e019168. PubMed ID: 33843247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
